ArticlePharmaceuticals (Basel, Switzerland)2025

Puerarin Targets HIF-1α to Modulate Hypoxia-Related Sphingolipid Metabolism in Diabetic Hepatopathy via the SPTLC2/Ceramide Pathway.

Mangui Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.